Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature
Angela Y Moore, Blakely S RichardsonArlington Center for Dermatology, Arlington, Texas, USAAbstract: Psoriasis is a chronic T-cell-mediated inflammatory disease that primarily affects the skin and joints. Patients with moderate to severe psoriasis constitute about 30% of the psoriasis population. Tr...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-04-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Online Access: | http://www.dovepress.com/long-term-use-of-adalimumab-in-the-treatment-of-moderate-to-severe-pla-a4267 |